Molecular barriers to direct cardiac reprogramming

Abstract

Myocardial infarction afflicts close to three quarters of a million Americans annually, resulting in reduced heart function, arrhythmia, and frequently death. Cardiomyocyte death reduces the heart’s pump capacity while the deposition of a non-conductive scar incurs the risk of arrhythmia. Direct cardiac reprogramming emerged as a novel technology to simultaneously reduce scar tissue and generate new cardiomyocytes to restore cardiac function. This technology converts endogenous cardiac fibroblasts directly into induced cardiomyocyte-like cells using a variety of cocktails including transcription factors, microRNAs, and small molecules. Although promising, direct cardiac reprogramming is still in its fledging phase, and numerous barriers have to be overcome prior to its clinical application. This review discusses current findings to optimize reprogramming efficiency, including reprogramming factor cocktails and stoichiometry, epigenetic barriers to cell fate reprogramming, incomplete conversion and residual fibroblast identity, requisite growth factors, and environmental cues. Finally, we address the current challenges and future directions for the field.

Key words： cardiac reprogramming; myocardial infarction; epigenetics; heart regeneration

References

1 AbadM (2017) Notch inhibition enhances cardiac reprogramming by increasing MEF2C transcriptional activity.Stem Cell Rep. doi:10.1016/j.stemcr.2017.01.025

2 AddisRC (2013) Optimization of direct fibroblast reprogramming to cardiomyocytes using calcium activity as a functional measure of success.J Mol Cell Cardiol60:97–106

3 ChenHP (2011) HDAC inhibition promotes cardiogenesis and the survival of embryonic stem cells through proteasome-dependent pathway.J Cell Biochem112:3246–3255

4 ChopraA (2012) Reprogramming cardiomyocyte mechanosensing by crosstalk between integrins and hyaluronic acid receptors.J Biomech45:824–831

5 ChristoforouN (2013) Transcription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming.PloS One8:e63577

6 Dal-PraS, HodgkinsonCP, MirotsouM, KirsteI, DzauVJ (2017) Demethylation of H3K27 is essential for the induction of direct cardiac reprogramming by miR combo.Circ Res. doi:10.1161/CIRCRESAHA.116.308741

7 FuY (2015) Direct reprogramming of mouse fibroblasts into cardiomyocytes with chemical cocktails.Cell Res25:1013–1024

8 Heart Attack Facts & Statistics|cdc.gov (2016) http://www.cdc.gov/heartdisease/heart_attack.htm. Accessed 7 Nov 2016

9 Heart Disease Fact Sheet|Data & Statistics|DHDSP|CDC (2016) http://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_heart_disease.htm. Accessed 7 Nov 2016

10 HiraiH, KikyoN (2014) Inhibitors of suppressive histone modification promote direct reprogramming of fibroblasts to cardiomyocytelike cells.Cardiovasc Res102:188–190

11 IedaM (2010) Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors.Cell142:375–386

12 IfkovitsJL, AddisRC, EpsteinJA, GearhartJD (2014) Inhibition of TGFβ signaling increases direct conversion of fibroblasts to induced cardiomyocytes.PloS One9:e89678

13 InagawaK (2012) Induction of cardiomyocyte-like cells in infarct hearts by gene transfer of Gata4, Mef2c, and Tbx5.Circ Res111:1147–1156

14 JayawardenaTM (2012) MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes.Circ Res110:1465–1473

15 JayawardenaTM (2015) MicroRNA induced cardiac reprogramming in vivo: evidence for mature cardiac myocytes and improved cardiac function.Circ Res116:418–424

16 KaramboulasC (2006) HDAC activity regulates entry of mesoderm cells into the cardiac muscle lineage.J Cell Sci119:4305–4314

17 KongYP, CarrionB, SinghRK, PutnamAJ (2013) Matrix identity and tractional forces influence indirect cardiac reprogramming.Sci Rep3:3474

18 LiY (2016) Tissue-engineered 3-dimensional (3D) microenvironment enhances the direct reprogramming of fibroblasts into cardiomyocytes by microRNAs.Sci Rep6:38815

19 LinZ, PuWT (2014) Strategies for cardiac regeneration and repair.Sci Transl Med6(239):239rv1

20 LiuZ (2016a) Re-patterning of H3K27me3, H3K4me3 and DNA methylation during fibroblast conversion into induced cardiomyocytes.Stem Cell Res16:507–518

21 LiuL (2016b) Targeting Mll1 H3K4 methyltransferase activity to guide cardiac lineage specific reprogramming of fibroblasts.Cell Discov2:16036

22 MaH, WangL, YinC, LiuJ, QianL (2015) In vivo cardiac reprogramming using an optimal single polycistronic construct.Cardiovasc Res108:217–219

23 MathisonM (2012) In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor.J Am Heart Assoc1:e005652

24 MathisonM (2014) ‘Triplet’ polycistronic vectors encoding Gata4, Mef2c, and Tbx5 enhances postinfarct ventricular functional improvement compared with singlet vectors.J Thorac Cardiovasc Surg148(1656):1664.e2

25 McKinseyTA, OlsonEN (2004) Cardiac histone acetylation–therapeutic opportunities abound.Trends Genet TIG20:206–213

26 MiskaEA (1999) HDAC4 deacetylase associates with and represses the MEF2 transcription factor.EMBO J18:5099–5107

27 MohamedTMA (2016) Chemical enhancement of in vitro and in vivo direct cardiac reprogramming.Circulation. doi:10.1161/CIRCULATIONAHA.116.024692

28 MorezC (2015) Enhanced efficiency of genetic programming toward cardiomyocyte creation through topographical cues.Biomaterials70:94–104

29 MuraokaN (2014) MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures.EMBO J33:1565–1581

30 ProtzeS (2012) A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells.J Mol Cell Cardiol53:323–332

31 QianL (2012) In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes.Nature485:593–598

32 SiaJ, YuP, SrivastavaD, LiS (2016) Effect of biophysical cues on reprogramming to cardiomyocytes.Biomaterials103:1–11

33 SongK (2012) Heart repair by reprogramming non-myocytes with cardiac transcription factors.Nature485:599–604

34 TakeuchiJK, BruneauBG (2009) Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors.Nature459:708–711

35 VaseghiHR (2016) Generation of an inducible fibroblast cell line for studying direct cardiac reprogramming.Genesis2000 (54):398–406

36 WangH (2014) Small molecules enable cardiac reprogramming of mouse fibroblasts with a single factor, Oct4.Cell Rep6:951–960

37 WangL (2015a) Stoichiometry of Gata4, Mef2c, and Tbx5 influences the efficiency and quality of induced cardiac myocyte reprogramming.Circ Res116:237–244

38 WangL (2015b) Improved generation of induced cardiomyocytes using a polycistronic construct expressing optimal ratio of Gata4, Mef2c and Tbx5.J Vis Exp JoVE. doi:10.3791/53426

39 YamakawaH (2015) Fibroblast growth factors and vascular endothelial growth factor promote cardiac reprogramming under defined conditions.Stem Cell Rep5:1128–1142

40 ZhaoY (2015) High-efficiency reprogramming of fibroblasts into cardiomyocytes requires suppression of pro-fibrotic signalling.Nat Commun6:8243

41 ZhouH, DicksonME, KimMS, Bassel-DubyR, OlsonEN (2015) Akt1/protein kinase B enhances transcriptional reprogramming of fibroblasts to functional cardiomyocytes.Proc Natl Acad Sci USA112:11864–11869

42 ZhouY (2016) Bmi1 is a key epigenetic barrier to direct cardiac reprogramming.Cell Stem Cell18:382–395